1 Although recent studies have reported a connection between NAION and the use of Semaglutide, a Glucagon-Like Peptide-1 (GLP-1) receptor agonist approved by the US Food and Drug Administration (FDA) in December 2017 for type 2 diabetes (T2D) and in December 2022 for obesity, further investigation is needed to fully understand the clinical implications of this association
Melanotan II is supplied as a lyophilized powder and should be reconstituted with bacteriostatic water (BAC water) before use
Neurosci Lett 607:108113 Salas MM, Clifford JL, Hayden JR, Iadarola MJ, Averitt DL (2017) Local resiniferatoxin induces long-lasting analgesia in a rat model of full thickness thermal injury
The most commonly reported side effects include nausea, diarrhea, constipation, and abdominal pain
Endogenous secretion of GLP-1 and GLP-2 was completely suppressed by GLP-1 infusion